Their actions were highly significant in affecting the long-term cancer risk assessment policies of the US and many countries, and they did so without being a part of either the advisory committees that set these polices in motion or of the agencies involved in regulatory decision making.
← all excerpts
The Gofman-Tamplin Cancer Risk Controversy and Its Impact on the Creation of BEIR I and the Acceptance of LNT.
1
—
—